BPC-157 — 5mg
109.99€
A three-amino-acid fragment of alpha-MSH studied for the same anti-inflammatory pathways as its parent hormone, and one of the few peptides researchers have found to show activity via the oral route in published models.
134.99€
Netto 134.99€
Wyłącznie do badań laboratoryjnych. Nie do stosowania u ludzi ani zwierząt.
KPV is a synthetic tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH). It retains the anti-inflammatory activity of the full α-MSH molecule while eliminating its melanogenic (skin-darkening) effects. Published research documents KPV's ability to modulate NF-κB signaling — the master inflammatory transcription factor — making it one of the most targeted anti-inflammatory peptides available for research.
KPV is a synthetic tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH). It retains the anti-inflammatory activity of the full α-MSH molecule while eliminating its melanogenic (skin-darkening) effects. Published research documents KPV's ability to modulate NF-κB signaling — the master inflammatory transcription factor — making it one of the most targeted anti-inflammatory peptides available for research.
KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-melanocyte stimulating hormone (alpha-MSH, amino acids 11-13). Despite its small size, it retains the full anti-inflammatory activity of the parent hormone. KPV is transported into intestinal epithelial cells via the peptide transporter PepT1, where it inhibits NF-kB activation, reducing pro-inflammatory cytokine production (TNF-alpha, IL-8). It also modulates immune cell function (reduces nitric oxide production in microglia, inhibits TNF-alpha in astrocytes). In mouse colitis models, orally delivered KPV significantly reduced disease severity. Its small size gives it favorable pharmacokinetic properties including oral bioavailability (unusual for peptides).
Poznanie mechanizmu: Partially characterized
100+ opublikowanych badań w zbiorze danych
Experimental — Strong preclinical data for colitis and inflammation. The PepT1 transport mechanism is well-published. No completed human RCTs. However, the alpha-MSH anti-inflammatory pathway is well-established in human physiology.
Moderate published literature. Strong NF-κB inhibition data. No human clinical trials.
None
Proszek liofilizowany: Room temp or refrigerated
Po rekonstytucji: Refrigerate, use within 30 days
Badany w kontekście: Gut inflammation, Skin inflammation, Anti-inflammatory, Autoimmune support, Neuroinflammation
Zgłaszany początek działania: Gut symptom improvement in 1-2 weeks; skin inflammation effects in 2-4 weeks
Zgłaszany czas trwania: 4-6 weeks; 200-500mcg SC daily or oral
Relacje społeczności: Very favorable safety profile due to natural origin (fragment of endogenous α-MSH). Users with IBD/IBS report reduced symptoms. No melanogenic effects unlike full-length α-MSH. Caution advised with active melanoma (melanocortin pathway). One of few peptides with documented oral bioactivity.
For research and educational use only. Source values are reproduced from the current PeptidesEuro content dataset and are not medical advice.
KPV tripeptide and anti-inflammatory activity
Demonstrated significant NF-κB inhibition and anti-inflammatory effects in intestinal epithelial cells.
Alpha-MSH peptides in colitis treatment
KPV showed therapeutic potential in experimental colitis models.
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
Orally delivered KPV decreases colitis severity in DSS- and TNBS-induced mouse models via PepT1-mediated transport and NF-kB inhibition.
Badania podano w celach informacyjnych. Większość przeprowadzono na modelach zwierzęcych lub komórkowych; ich wyniki nie dowodzą bezpieczeństwa ani działania u ludzi.
KPV … KPV & GHK-Cu (injections) have helped me … KPV has helped me dramatically
KPV … I started taking KPV subq 250 mcg once daily at night. … I feel very fatigued and almost like a low grade common cold symptoms every day since I started.
KPV … I started KPV 5 days ago … I have been feeling nauseous every day since
Based on 3 qualifying reports from 3 threads. 35 candidates excluded as duplicates, promotion, deleted content, or lacking concrete personal experience. Reddit self-reports are not medical evidence or proof of causation.
Pytania i odpowiedzi zapisane dla tego produktu.
Yes. KPV is one of the few peptides with documented oral bioactivity. Published research shows it crosses the intestinal epithelium via PepT1 transport, making it uniquely suited for gut-targeted anti-inflammatory applications. Both injectable and oral forms are studied.
No. Unlike full-length α-MSH or Melanotan, KPV retains anti-inflammatory properties without melanogenic effects.
A tripeptide (three amino acids: Lys-Pro-Val) derived from alpha-MSH, studied for anti-inflammatory properties.
Ten produkt nie ma jeszcze opinii.
Dane produktu, źródła i zamówienie pozostają ze sobą powiązane.

Wybierz związek i rozmiar fiolki w katalogu.

Otwórz szczegóły produktu i powiązane badania.

Zapisz źródła do swojej dokumentacji.
Struktura, dostępne rozmiary i uwagi dotyczące obchodzenia się w jednym miejscu.
Strony produktów prowadzą do badań dotyczących każdego związku.
Zamówienia i ich szczegóły pozostają na Twoim koncie.
Cena, dostępność i podatek przy każdym produkcie.
PeptidesEuro is a research materials supplier operated by Pepticore LLC. We provide high-purity peptides and research compounds for in-vitro laboratory and scientific research purposes. All products are sold strictly for research use only and are not intended for human or animal consumption.
No. All products sold through meimx.com are intended strictly for in-vitro laboratory and scientific research purposes only. They are not intended for human or animal consumption, injection, ingestion, inhalation, or any form of administration to living organisms. By purchasing from PeptidesEuro, you acknowledge and agree to these terms as outlined in our Terms of Service.
No. Our products have not been evaluated, approved, or authorized by the U.S. Food and Drug Administration (FDA) or any other regulatory body. They are not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. PeptidesEuro is not a compounding pharmacy or outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
No. PeptidesEuro does not provide medical advice, treatment recommendations, or dosing instructions. Any information on our website, including product descriptions and referenced research, is provided for educational and informational purposes only. If you have medical questions, please consult a licensed healthcare provider.
Research Use Only means that our products are sold exclusively as reference standards and research materials for use in laboratory and scientific research settings. Purchasers agree to use all products solely for legitimate research purposes in compliance with all applicable laws and regulations.
Przeglądaj katalog albo odpowiedz na jedno pytanie w wyszukiwarce produktów.